JG
ANAB icon

Jefferies Group’s AnaptysBio ANAB Stock Holding History

Jefferies Group’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,710
Closed -$123K – 1640
2021
Q1 		$123K Sell
5,710
-5,241
-48% -$132K ﹤0.01% 1430
2020
Q4 		$235K Sell
10,951
-5,529
-34% -$134K ﹤0.01% 1338
2020
Q3 		$243K Buy
+16,480
New +$297K ﹤0.01% 1145
2020
Q1 		– Sell
-30,000
Closed -$488K – 2025
2019
Q4 		$488K Buy
30,000
+19,013
+173% +$450K ﹤0.01% 1821
2019
Q3 		$384K Buy
+10,987
New +$523K ﹤0.01% 2024

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Jefferies Group's ANAB Position: Q2 2021 in Review

Jefferies Group sold out of AnaptysBio (ANAB) in Q2 2021, closing a stake of 5,710 shares — an estimated $123K sold.

Jefferies Group first reported a position in ANAB in Q3 2019 and held it in 5 quarters. The position peaked at $488K in Q4 2019. 122 funds tracked by Wall St. Rank hold ANAB as of Q2 2021.

  • Jefferies Group reported no remaining AnaptysBio position as of Q2 2021 after selling out during the quarter.
  • Jefferies Group sold 5,710 AnaptysBio shares in Q2 2021, an estimated $123K.
  • Jefferies Group first reported a position in AnaptysBio in Q3 2019 and held it in 5 quarters.
  • Jefferies Group's AnaptysBio position peaked at $488K in Q4 2019.
  • 122 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2021.

Based on Jefferies Group's 13F filing for Q2 2021, filed 16 Aug 2021.